“Does anyone have any examples of OTC pharma sto
Post# of 154592
(Total Views: 482)
Posted On: 05/03/2020 5:29:43 PM
Re: Riztheinvestor #31686
“Does anyone have any examples of OTC pharma stocks that made it big ? I can’t find any examples. I know CYDY is different but what are the odds that this blows up.”
CYDY is an example of an OTC stock that has NEARLY made it big. Myself and others, who have been here 5+ years (some less), loaded our pockets in the .30 range (some under .30). You do the match, but a run from .30 to $3 is nothing to balk at.
The question now is: how far will the SP increase from $3. Well, HIV combo will get approved and cancer looks very promising and those to could equal an SP well above $20-30 (investors have done the math on HIV combo and I believe it’s at least an SP in the $10 range when sales are rolling in). COVID19 is extremely promising, but I’m still 50/50 on COVID19 as trial enrollment is slow and the patient pool continues to shrink as cases decrease and treatments like remdesivir are approved.
You have to assess your own risk level, financial situation and goals and determine if buying more shares is worth it to you.
CYDY is an example of an OTC stock that has NEARLY made it big. Myself and others, who have been here 5+ years (some less), loaded our pockets in the .30 range (some under .30). You do the match, but a run from .30 to $3 is nothing to balk at.
The question now is: how far will the SP increase from $3. Well, HIV combo will get approved and cancer looks very promising and those to could equal an SP well above $20-30 (investors have done the math on HIV combo and I believe it’s at least an SP in the $10 range when sales are rolling in). COVID19 is extremely promising, but I’m still 50/50 on COVID19 as trial enrollment is slow and the patient pool continues to shrink as cases decrease and treatments like remdesivir are approved.
You have to assess your own risk level, financial situation and goals and determine if buying more shares is worth it to you.
(2)
(0)